BCM
ARA

Bridgeway Capital Management’s American Renal Associates Holdings, Inc ARA Stock Holding History

Bridgeway Capital Management’s Portfolio ARA Stock Details ARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-43,500
Closed -$288K – 1436
2020
Q1 		$288K Sell
43,500
-10,100
-19% -$88K 0.01% 938
2019
Q4 		$556K Buy
+53,600
New +$458K 0.01% 934

Other funds holding ARA

CP
Centerbridge Partners New York $38.1M AUM 9.24% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
WIC
Whitegate Investment Counselors Concord, New Hampshire $351M AUM 16.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bridgeway Capital Management's ARA Position: Q2 2020 in Review

Bridgeway Capital Management sold out of American Renal Associates Holdings, Inc (ARA) in Q2 2020, closing a stake of 43,500 shares — an estimated $288K sold.

Bridgeway Capital Management first reported a position in ARA in Q4 2019 and held it in 2 quarters. The position peaked at $556K in Q4 2019. 56 funds tracked by Wall St. Rank hold ARA as of Q2 2020.

  • Bridgeway Capital Management reported no remaining American Renal Associates Holdings, Inc position as of Q2 2020 after selling out during the quarter.
  • Bridgeway Capital Management sold 43,500 American Renal Associates Holdings, Inc shares in Q2 2020, an estimated $288K.
  • Bridgeway Capital Management first reported a position in American Renal Associates Holdings, Inc in Q4 2019 and held it in 2 quarters.
  • Bridgeway Capital Management's American Renal Associates Holdings, Inc position peaked at $556K in Q4 2019.
  • 56 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q2 2020.

Based on Bridgeway Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.